Quiz #1

#1. When deciding on the right oncological treatment strategy, which of the following factors are considered?

Performance status

Social status

IGHV mutational status

Karnofsky performance status scale

Smoking status

#2. What are the immunohistochemistry markers in Luminal A cancers?

ER+ and/or PR+, HER2-, KI67-

ER-, PR- & HER2-, basal marker+

ER+ and/or PR+, HER2-, KI67+

ER-, PR-, HER2+

CA-125+, ER+, PR-

#3. What are the immunohistochemistry markers in Luminal B cancers?

ER+ and/or PR+, HER2-, KI67-

ER-, PR- & HER2-, basal marker+

ER+ and/or PR+, HER2-, KI67+

ER-, PR-, HER2+

CA-125+, ER+, PR-

#4. Which of the following are a prognostic factor for invasive breast cancer?

Age at first time birth

Nulliparity

Age at menarche

Tumor size <2 cm

Menopause

#5. Which of the following can distinguish if a possible predictive factor for invasive breast cancer exist?

Tumor size <2 cm

Involvement of axillary nodes

Age at menarche

Histologic subtype

Age of patient

#6. What is the definition of neo-adjuvant therapy?

Antineoplastic treatment offered following surgical removal of the tumor

Surgery

Antineoplastic treatment offered during surgical removal of the tumor

Watchful waiting treatment

Therapy offered before the primary therapy, which often is surgery.

#7. When was chemotherapy added to the line of treatment?

1855

After World War I

1900

After World War II

1989

#8. How many women are diagnosed with breast cancer in Denmark? (Lifetime risk)

2%

5%

10%

12%

15%

#9. Which of the following are a part of the triple test?

Mammography

X-ray

MRI

CT scan

Bone density scan (DEXA)

#10. Which of the following are an antineoplastic anti-estrogen drug (endocrine therapy)?

Epirubicin

Docetaxel

Tamoxifen

Trastuzumab

Cyclophospamid

#11. The delivered energy from radiotherapy is measured in which unit?

Joule

Watt

Newton

Fractions

Gray

Oncologic Treatment of Breast Cancer